INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Jun 21, 2021 |
Director, President and Chief Scientific
Trans History: 581
|
Director, President and Chief Scientific | Open market or private sale of non-derivative or derivative security | 2,276 | $543.13 |
| Jun 23, 2021 |
Director, President and Chief Scientific
Trans History: 581
|
Director, President and Chief Scientific | Other acquisition or disposition | -- | -- |
| Jun 23, 2021 |
Director, President and Chief Scientific
Trans History: 581
|
Director, President and Chief Scientific | Other acquisition or disposition | -- | -- |
| Jun 23, 2021 |
Director, President and Chief Scientific
Trans History: 581
|
Director, President and Chief Scientific | Other acquisition or disposition | -- | -- |
| Jun 24, 2021 |
Director, President and Chief Scientific
Trans History: 581
|
Director, President and Chief Scientific | Bona fide gift | 211,585 | -- |
| Jun 24, 2021 |
Director, President and Chief Scientific
Trans History: 581
|
Director, President and Chief Scientific | Bona fide gift | 211,585 | -- |
| Jun 25, 2021 |
Director
Trans History: 402
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,084 | $371.40 |
| Jun 25, 2021 |
Director
Trans History: 402
|
Director | Open market or private sale of non-derivative or derivative security | 2,084 | $549.00 |
| Jun 25, 2021 |
Director
Trans History: 402
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,084 | -- |
| Jun 28, 2021 |
Director
Trans History: 402
|
Director | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.